EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beta-blockers in atrial fibrillation—trying to make sense of unsettling results

Markus Meyer iD, Daniel Lustgarten

EP Europace · 16.02.2023 · 25 (2) · 260-262

DOI: 10.1093/europace/euad010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EP Europace, online erschienen am 07.02.2023. Verfasst von Markus Meyer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Lillehei Heart Institute, University of Minnesota, 2231 6th Street SE, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Cardiomyopathies. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureCardiomyopathiesHumansAdrenergic beta-AntagonistsHeart RateStroke Volume

Stichwörter der Autor:innen

Atrial fibrillationBeta-blockersDiastolic dysfunctionHeart failure with preserved ejection fraction

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Medicine, Lillehei Heart Institute, University of Minnesota, 2231 6th Street SE, Minneapolis, MN 55455, USA.
  • Department of Medicine, Cardiovascular Research Institute of Vermont, University of Vermont, Burlington, VT, USA.

ORCID-Profile: Markus Meyer

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Meyer, M., & Lustgarten, D. (2023). Beta-blockers in atrial fibrillation—trying to make sense of unsettling results. EP Europace, 25(2), 260-262. https://doi.org/10.1093/europace/euad010

Vancouver

Meyer M, Lustgarten D. Beta-blockers in atrial fibrillation—trying to make sense of unsettling results. EP Europace. 2023;25(2):260-262. doi:10.1093/europace/euad010

BibTeX
@article{Meyer2023,
  author = {Meyer, Markus and Lustgarten, Daniel},
  title = {Beta-blockers in atrial fibrillation—trying to make sense of unsettling results},
  journal = {EP Europace},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {260--262},
  doi = {10.1093/europace/euad010}
}
Kostenlos starten →